Understanding these structural and biochemical principles opens new opportunities for drug discovery—for example, developing small molecules or RNA-based therapeutics that enhance NUDT21 stability or restore distal PAS recognition could represent a novel strategy to rebalance APA and dampen excessive inflammatory gene expression in ARDS and related diseases. The gene discussed is NUDT21; the disease is acute respiratory distress syndrome.